Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction

Maarten de Mulder,Tjeerd van der Ploeg,Guus A. de Waard,Eric Boersma,Victor A. Umans

Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction

2011

Maarten de Mulder
Tjeerd van der Ploeg
Guus A. de Waard
Eric Boersma
Victor A. Umans

Objective: Admission plasma glucose (APG) is a biomarker that predicts mortality in myocardial infarction (MI) patients. Therefore, APG may improve risk stratification based on the

Keywords:

Net reclassification improvement
Cardiology
Internal medicine
Diabetes mellitus
Myocardial infarction
Framingham Risk Score
Indexation
Biomarker (medicine)
Acute coronary syndrome
Medicine
risk stratification
plasma glucose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations